Online Now: PD-L1 and CD58 co-regulated by CMTM6 play yin and yang to shape anti-tumor immunity dlvr.it/SvnM55

Online Now: Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer dlvr.it/SvpxWx

Online Now: Beyond bacteria: How the intratumor mycobiome modulates lung adenocarcinoma progression dlvr.it/Swl6Sj

.Haiying Cheng helped identify RICTOR—a gene amplified in patients with a risk of lung cancer spreading to the brain. With an American Cancer Society grant, she hopes to determine if targeting RICTOR can treat metastases. #LungCancerAwarenessMonth Albert Einstein College of Medicine - Official bit.ly/3SiP8Py

.Haiying Cheng helped identify RICTOR—a gene amplified in patients with a risk of lung cancer spreading to the brain. With an American Cancer Society grant, she hopes to determine if targeting RICTOR can treat metastases. #LungCancerAwarenessMonth Albert Einstein College of Medicine - Official bit.ly/3SiP8Py

According to a new Journal of the @NCCN study, real world data shows impact of immunotherapy in populations underrepresented in clinical trials. Learn more: nccn.org/home/news/news…

Lung cancer significantly contributes to morbidity and mortality among people with HIV. A recently published article in Clinical Lung Cancer analyzes clinicopathological characteristics, including immunotherapy outcomes, for 174 #PWH diagnosed with lung cancer. bit.ly/46T6zKk

Great work Haiying Cheng Ece Cali Daylan, MD, PhD Montefiore Health System providing key information about an understudied patient population!

Drs. Haiying Cheng & Matthew Lee found patients treated with #immunotherapy for Non-Small Cell #LungCancer had similar survival, progression-free survival, & treatment duration results—regardless of race, ethnicity, insurance, & income. Albert Einstein College of Medicine - Official Journal of the @NCCN bit.ly/4ajwWMu

Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers dlvr.it/T03K93

👀💪👏 Looks like our Montefiore Health System thoracic onc team is on a roll addressing critical questions abt underrepresented pt populations- URM and IO benefit this time around! 🎉 to our new faculty (Monte grad) Matt Lee/ Haiying Cheng and others!

Online Now: Integrated proteogenomic characterization of glioblastoma evolution dlvr.it/T1QVyq

🔥Standard and Emerging First-Line Options in EGFR-Mutated NSCLC 🎙️Stephanie Saw ✅Brief history of EGFR-TKIs ✅Single / Combined approach ✅Plasma EGFRm and co-mutations as biomarker ✅Trial designs ✅How to choose treatment at 1st line #ASCO24 #LCSM OncoAlert ASCO

Why do some patients benefit less than others from precision cancer medicine? We are excited to share our paper "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling” out in Nature Communications. nature.com/articles/s4146… 🧵

Join Balazs Halmos, Haiying Cheng, & Brendon Stiles for PER's New York #LungCancer Symposium. Learn about multidisciplinary treatment, the latest in immunotherapy, & engage in real-world case discussions. FREE for Montefiore staff (DM for code). bit.ly/4fhrkni

IL-1 signaling in aging and cancer: An inflammaging feedback loop unveiled dlvr.it/TGC7LZ

New #JITC review: Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review bit.ly/40jqaCc @mcquadeMDLAc Marco Ruella Chris(tine) Spencer Allison Betof Warner, MD, PhD Tullia Bruno, PhD

Further to below, recent US report of tempus data on smoking vs non smoking related small cell lung cancer, quite different entities clinical-lung-cancer.com/action/showPdf… #lcsm

Cancer of unknown primary site encompasses a heterogeneous group of metastatic cancers with an unidentified primary site of origin. Putative site-specific therapy and empirical chemotherapy are acceptable treatment options. Read the Clinical Practice article “Cancer of Unknown

Online Now: The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets dlvr.it/TL3d9s